BRIEF-Mesa Biotech Says Receives Emergency Use Authorization From FDA For A 30 Minute Point Of Care Molecular COVID-19 TEST

March 24 (Reuters) -

* MESA BIOTECH SAYS RECEIVES EMERGENCY USE AUTHORIZATION FROM FDA FOR A 30 MINUTE POINT OF CARE MOLECULAR COVID-19 TEST

* MESA BIOTECH - TO IMMEDIATELY BEGIN SHIPPING RAPID, MOLECULAR SARS-COV-2 TEST Source text for Eikon: Further company coverage: [ ]